Details of the Drug Reposition

General Information of This Drug (ID: DMPVUGE)

• Drug Name: CDX-1127 (DMPVUGE)

Information on Drug Reposition of This Drug

3 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Solid tumour/cancer	DISZR48F	2A00-2F9Z	Phase 1	[1]
leukaemia	DISS7D1V	2A60-2B33	Phase 1	[1]
Lymphoma	DISN6V4S	2A80-2A86	Phase 1	[1]

References

• [1] ClinicalTrials.gov (NCT02284971) Pilot Study of SBRT and CDX-1127 in Prostate Cancer. U.S. National Institutes of Health.